Im Jahr 2017 wurden durch das KHFI 115 Originalarbeiten sowie 12 Reviews/Editorials in begutachteten Zeitschriften mit einem kumulierten Impact Factor von 631 publiziert.

Eine vollständige Liste aller Publikationen 2013-2017 findet man hier: Campus All 2013-17

10 ausgewählte Publikationen aus 2017:  12345678910

Kim W, Hamm C. The Future of TAVI. Eur Heart J. 2017;38(36):2704-2707. [PubMed]
Baumgartner H, Falk V, Bax J, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-2791. [PubMed]
Klingenberg R, Aghlmandi S, Liebetrau C, et al. Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes. Eur Heart J. 2017;38(47):3493-3502. [PubMed]
Olsson K, Wiedenroth C, Kamp J, et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir J. 2017;49(6). [PubMed]
Wiebe J, Dörr O, Ilstad H, et al. Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison. JACC Cardiovasc Interv. 2017;10(5):477-485. [PubMed]
Rieth A, Richter M, Gall H, et al. Hemodynamic phenotyping based on exercise catheterization predicts outcome in patients with heart failure and reduced ejection fraction. J Heart Lung Transplant. 2017;36(8):880-889. [PubMed]
Kriechbaum S, Wiedenroth C, Wolter J, et al. N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. December 2017. [PubMed]
Nef H, Wiebe J, Foin N, et al. A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives. Int J Cardiol. 2017;227:127-133. [PubMed]
Kim W, Liebetrau C, Renker M, et al. Transfemoral aortic valve implantation using a self-expanding transcatheter heart valve without pre-dilation. Int J Cardiol. 2017;243:156-160. [PubMed]
Boeder N, Johnson V, Dörr O, et al. Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis. Int J Cardiol. 2017;231:73-77. [PubMed]